Phylo closed a $13.5 million seed round to launch Biomni Lab, an AI‑native integrated biology environment that embeds agentic AI into lab workflows for planning, execution and collaboration. The round was co‑led by Andreessen Horowitz and Menlo Ventures’ Anthology Fund and backs a spinout from Stanford’s Biomni project. Phylo positions Biomni Lab as an automation and decision‑support layer for life‑science teams; early users include Ginkgo Bioworks, which reported expedited transcriptomic and cell‑painting workflows. Founding scientists and advisors include notable names from Stanford and industry (Jure Leskovec, Le Cong, Carolyn Bertozzi among advisors), underscoring the startup’s technical pedigree. The financing highlights persistent investor interest in applied AI tools that address bench‑to‑data bottlenecks. The company will maintain its open‑source roots while building commercial features to accelerate biological research across biotech and pharma.